Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug

When scientific journals publish expressions of concerns, they have an obligation to do so prominently, Ed Silverman writes.

“These sides aren't talking to each other. And there's a lot riding on it”: the podcast trying to bridge MAHA and public health.

New AI tools could screen existing CT scans to asses risk for heart disease. But, who'll pay for it, and will it improve health outcomes?

“Patients don’t experience illness in a vacuum,” writes Uché Blackstock.